National Core Facility for Biopharmaceuticals

Mission

National Core Facility for Biopharmaceuticals (NCFB) is aimed to make efficient use of the established research resources and provide professional high-tech service and expert consultation to academic and industrial PIs in Taiwan.

NCFB integrates Core Facility Program for Biotechnology and Pharmaceuticals, Resource Centers developed during the National Research Program for Biopharmaceuticals, the National Core Facility Program for Biotechnology, and R & D teams with prescient technology in Taiwan into a new platform. Taking the advantage of established experiences, this platform goes on developing cutting-edge technologies and provides professional high-tech service and expert consultation. To fulfill the needs of academic and industrial PIs, regular users’ committee and annul review is scheduled.
NCFB not only offers an excellent environment for the development of precision medicine, biotechnology and pharmaceutical research, but also enhances the transition from basic research to clinical trial. NCFB includes six platforms:

Core Facility

Organizational Chart

National Core Facility for Biopharmaceuticals Organizational Chart

Core Facility

National Core Facility for Biopharmaceuticals
3rd National Core Facility Program for Biotechnology(2017/05/01~2019/04/30)
  • A4
    Transgenic Mouse Core Facility
  • A11
    Humanized Mouse Platform: Patient Derived Tumor, Gut Microbiota Transplantation And Gene Modification Service
  • A12
    Taiwan Animal Consortium-National Phenotyping and Drug Testing Center
  • A9
    Zebrafish platforms for disease and toxicity test
  • A10
    Bioimaging Core Facility
  • C1
    Genomics Center for Clinical and Biotechnological Applications
  • C2
    National Center for Genome Medicine
  • C5/TR6
    Pharmacogenomics Core Laboratory
  • C6
    RNAi core facility
  • E2
    Bioinformatics Core Facility for Biotechnology and Pharmaceuticals
  • GP1
    National Biomedical Data Service and Analysis Computing Platform
  • D4
    Synchrotron Protein Crystallography Facility
  • SB2
    The establishment of a clinico-pathological network and database on hepatocellular carcinoma in Taiwan and Taiwan lung cancer tissue/specimen and information resource center
  • iPSC
    Human Disease iPS Cell Service Consortium
2nd National Core Facility Program for Biotechnology(2015/05/01~2017/04/30)
  • A4
    Transgenic Mouse Models Core Facility
  • A8
    Genetic Engineered Murine Model Services (GEMMS)
  • A9
    Taiwan Zebrafish Core Facility-human disease model center
  • A10
    建構南台灣生醫光學影像核心平台
  • C1
    High-throughput Genome Analysis Core Facility
  • C2
    National Center for Genome Medicine
  • C5
    Integrated Core Facility for Functional Genomics
  • C6
    標靶式操控基因表達核心設施
  • D4
    The Synchrotron Radiation Protein Crystallography Core Facility
  • E2
    Bioinformatics Consortium of Taiwan
1st National Core Facility Program for Biotechnology(2011/05/01~2015/04/30)
  • A4
    基因轉殖鼠核心設施
  • A8
    基因改造疾病模式鼠核心設施
  • C1
    高通量基因體分析核心設施
  • C2
    國家基因體醫學研究中心
  • C5
    整合性功能體學核心實驗室
  • C6
    核醣核酸干擾設施平台
  • D3
    蛋白質結構分析核心設施
  • D4
    同步輻射蛋白質結晶學核心設施
  • E2
    台灣生物資訊核心設施
  • E3
    台灣生物資訊聯盟

Program Office

Director

Hsin-Chen Lee, Ph.D.

Professor
Institute of Pharmacology,
School of Medicine,
National Yang-Ming University

R.512, 5F, Shouren Building, No. 155, Sec. 2, Linong St., Taipei, 11221 Taiwan (ROC)
TEL: +886-2-2826-7327
hclee2@ym.edu.tw

Office Staff
Manager Dr. Chen-I Lin
+886-2-28213037
Specialist Jen-Chi Hsu
+886-2-28216682
Specialist Huei-Chi Hsiang
+886-2-28216682
Specialist Hsiu-Ling Lin
+886-2-28216682